Suppr超能文献

具有抗糖尿病特性的绿色合成纳米颗粒的表征。系统评价。

Characterization of Green Synthesized Nanoparticles with Anti-diabetic Properties. A Systematic Review.

作者信息

Loyola-Leyva Alejandra, Hernandez-Vidales Karen, Ruiz-Garcia Jaime, Loyola-Rodriguez Juan Pablo

机构信息

Biological Physics Laboratory, Physics Institute. Autonomous University of San Luis Potosí, (Universidad Autónoma de San Luis Potosí), Av. Manuel Nava #6, Zona Universitaria, C.P. 78290, San Luis Potosí, S.L.P., México.

Institute of Applied Science and Technology, National Autonomous University of Mexico, Cto. Exterior S/N, C.U., Coyoacán, C.P. 04510, Ciudad de México, México.

出版信息

Curr Diabetes Rev. 2025;21(7):67-85. doi: 10.2174/0115733998306451240425135229.

Abstract

BACKGROUND

Plants are used in medicine because they are low-cost, widely available, and have few side effects (compared to pharmacological treatment). Plants have phytocompounds with antidiabetic properties that can be delivered using nanoparticles (NPs).

OBJECTIVE

To describe the antidiabetic properties of green synthesized NPs (GSNPs) and their characterization methods.

METHODS

Three databases were consulted using the terms "type 2 diabetes mellitus," "antidiabetic effects," "phytochemicals," "plants," and "nanoparticles." Studies describing the antidiabetic effects ( or animal models) of NPs synthesized by plant extracts and characterizing them through UV-Vis spectroscopy, FTIR, XRD, SEM, TEM, and DLS were included.

RESULTS

16 studies were included. studies reported enzyme inhibition values between 11% () and 100% () for alfa-amylase and between 41.1% (M. zapota) and 100% () for alfa-glucosidase. Animal studies with Wistar Albino rats having diabetes (induced by alloxan or streptozotocin) reported improved blood glucose, triglycerides, total cholesterol, LDL, and HDL after treatment with GSNPs. Regarding characterization, NP sizes were measured with DLS (25-181.5 nm), SEM (52.1-91 nm), and TEM (8.7-40.6 nm). The surface charge was analyzed with zeta potential (-30.7 to -2.9 mV). UV-Vis spectroscopy was employed to confirm the formations of AgNPs (360-460 nm), AuNPs (524-540 nm), and ZnONPs (300-400 nm), and FTIR was used to identify plant extract functional groups.

CONCLUSION

GSNP characterization (shape, size, zeta potential, and others) is essential to know the viability and stability, which are important to achieve health benefits for biomedical applications. Studies reported good enzyme inhibition percentages in studies, decreasing blood glucose levels and improving lipid profiles in animal models with diabetes. However, these studies had limitations in the methodology and potential risk of bias, so results need careful interpretation.

摘要

背景

植物被用于医学领域,因为它们成本低廉、易于获取且副作用较少(与药物治疗相比)。植物含有具有抗糖尿病特性的植物化合物,这些化合物可以通过纳米颗粒(NPs)来递送。

目的

描述绿色合成纳米颗粒(GSNPs)的抗糖尿病特性及其表征方法。

方法

使用“2型糖尿病”“抗糖尿病作用”“植物化学物质”“植物”和“纳米颗粒”等术语查阅了三个数据库。纳入了描述植物提取物合成的纳米颗粒的抗糖尿病作用(或动物模型)并通过紫外可见光谱、傅里叶变换红外光谱、X射线衍射、扫描电子显微镜、透射电子显微镜和动态光散射对其进行表征的研究。

结果

纳入了16项研究。一些研究报告了α-淀粉酶的酶抑制值在11%()至100%()之间,α-葡萄糖苷酶的酶抑制值在41.1%(人心果)至100%()之间。对用四氧嘧啶或链脲佐菌素诱导糖尿病的Wistar白化大鼠进行的动物研究报告称,用GSNPs治疗后血糖、甘油三酯、总胆固醇、低密度脂蛋白和高密度脂蛋白有所改善。关于表征,通过动态光散射测量纳米颗粒大小(25 - 181.5纳米)、扫描电子显微镜(52.1 - 91纳米)和透射电子显微镜(8.7 - 40.6纳米)。用zeta电位分析表面电荷(-30.7至-2.9毫伏)。采用紫外可见光谱确认银纳米颗粒(360 - 460纳米)、金纳米颗粒(524 - 540纳米)和氧化锌纳米颗粒(300 - 400纳米)的形成,并使用傅里叶变换红外光谱识别植物提取物官能团。

结论

GSNP表征(形状、大小、zeta电位等)对于了解其生存能力和稳定性至关重要,这对于实现生物医学应用的健康益处很重要。一些研究报告了良好的酶抑制百分比,在糖尿病动物模型中降低了血糖水平并改善了血脂状况。然而这些研究在方法上存在局限性且有潜在的偏倚风险,因此结果需要谨慎解读。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验